Naryx Pharma, Inc. Announces The Election Of Geron Corporation Executive Alan B. Colowick To Its Board Of Directors

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Naryx Pharma, Inc., a leader in the development of new therapies for patients with chronic sinusitis, announced today that Alan B. Colowick, M.D., M.P.H., has been elected to its Board of Directors.